NCT07216443 2026-04-15
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Phase 2 Recruiting
Clinical Trials
19 trialsNCT06135415 2026-03-25
TirbAKare
Almirall, S.A.
Phase 3 Completed
NCT07120945 2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA Recruiting
NCT07144345 2026-03-05
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Sun Pharmaceutical Industries Limited
Phase 3 Active not recruiting
NCT07144852 2026-02-20
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Sun Pharmaceutical Industries Limited
Phase 3 Active not recruiting
NCT06815939 2026-01-29
OPTICS
DL Analytics
Phase NA Recruiting
NCT02158858 2025-10-08
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Phase 1/2 Completed
NCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT05636800 2024-08-06
Microwave Treatment for Actinic Keratosis
Blackwell Device Consulting
Phase NA Active not recruiting
NCT02121873 2023-07-20
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Atossa Therapeutics, Inc.
Completed
NCT00106691 2023-06-12
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
GTx
Phase 3 Completed
NCT02844777 2023-01-12
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Vidac Pharma
Phase 2 Completed
NCT03285477 2021-04-13
AK003
Almirall, S.A.
Phase 3 Completed
NCT03285490 2021-03-10
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)
Almirall, S.A.
Phase 3 Completed
NCT00128661 2019-03-08
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
GlaxoSmithKline
Phase 3 Completed
NCT01752114 2018-03-01
Early Diagnosis of Pulmonary Nodules
Integrated Diagnostics
Completed
NCT02539615 2016-01-25
A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old
Atossa Therapeutics, Inc.
Phase 3 Withdrawn
NCT01752101 2015-01-09
Identification of a Plasma Proteomic Signature for Lung Cancer
Integrated Diagnostics
Completed
NCT00036283 2008-09-29
Chemoprevention of Oral Premalignant Lesions
Pfizer
Phase 2 Completed